Anthony Sabatelli Testifies Before CT’s Finance Committee
Mar 25th, 2015 by Thomas DeFelice | News | Recent News & Articles |
Dr. Anthony Sabatelli, Partner and Chair of Dilworth IP’s Pharmaceutical and Biotechnology group has recently also been named Chair of CURE’s (Connecticut United for Research Excellence) Government Affairs Committee. In that role last week, he testified before the State of Connecticut’s Finance, Revenue, and Bonding Committee advocating for the continued R&D tax credit for businesses as a “competitive necessity”, especially as it impacts the state’s growing biotechnology and pharmaceutical industry.